Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

참고문헌 (13)

1. Ahn Young Eun, "Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis", Gut and Liver, 15(2), pp.284~294 (2021), 거트앤리버 소화기연관학회협의회[DOI]
2. Li S, "Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma : a multi-center propensity score matched analysis of real-world practice", Hepatobiliary Surg Nutr, 10, pp.631~645 (2021)
3. Li S, "Transarterial infusion chemotherapy with FOLFOX could be an effective and safe treatment for unresectable intrahepatic cholangiocarcinoma", J Oncol, 2022, pp.2724476~ (2022)
4. Li S, "Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A", B hepatocellular carcinoma patients beyond Milan criteria : an interim analysis of a multi-center, phase 3, randomized, controlled clinical trial, 2021, pp.39(15_suppl), 4008~
5. Lan XB, "The upward trend in the immunotherapy utilization for hepatobiliary cancers", Hepatobiliary Surg Nutr, 10, pp.692~695 (2021)
6. Campani C, "Systemic treatment of hepatocellular carcinoma : the times they are a-changin’", Hepatobiliary Surg Nutr, 10, pp.893~895 (2021)
7. Deng M, "Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy", Ann Med, 54, pp.803~811 (2022)
8. Finn RS, "Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma", N Engl J Med, 382, pp.1894~1905 (2020)
9. Mei J, "Anti-PD-1 immunotherapy improves the efficacy of hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma", J Hepatocell Carcinoma, 8, pp.167~176 (2021)
10. Obi S, "Current status of hepatic arterial infusion chemotherapy", Liver Cancer, 4, pp.188~199 (2015)
11. Zhou J, "Guidelines for the diagnosis and treatment of hepatocellular carcinoma(2019 edition)", Liver Cancer, 9, pp.682~720 (2020)
12. He M, "Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion : a randomized clinical trial", JAMA Oncol, 5, pp.953~960 (2019)
13. Li QJ, "Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma : a randomized phase III trial", J Clin Oncol, 40, pp.150~160 (2022)

관련 논문AI추천